Oral anticoagulants and fecal immunochemical tests for hemoglobin: do they go together?

Endoscopy 2023; 55(05): 456-457
DOI: 10.1055/a-2025-0963

Editorial

Referring to Rasmussen S et al. p. 444–455

¹Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology – BIPS, Bremen, Germany

²Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany

References
1 Rasmussen S, Torp-Pedersen C, Andersson K. The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study. Endoscopy 2023; 55: 444-455
2 Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 2010; 304: 2513-2520
3 Brenner H, Calderazzo S, Seufferlein T. et al. Effect of a single aspirin dose prior to fecal immunochemical testing on test sensitivity for detecting advanced colorectal neoplasms: a randomized clinical trial. JAMA 2019; 321: 1686-1692
4 Lau LH, Guo CL, Yip TC. et al. Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis. Gut 2022; 71: 100-110